Will Big pharma profit from DSM-5? By: MarketWatch June 05, 2013 at 07:36 AM EDT Binge eating and hoarding diagnoses may be new opportunities for drug companies Read More >> Related Stocks: Novartis Ag ADR Pfizer Shire Plc Ads